Sector consensus Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 186.86 CHF | +0.90% |
|
+0.39% | - |
| 07-29 | Align Technology to add directors, launch review after deal with Elliott | RE |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 680.7 | +21.08% | 23 | ||||||
| 207 | +10.38% | 21 | ||||||
| 272.94 | +16.14% | 18 | ||||||
| 415.64 | +31.53% | 27 | ||||||
| 265,216.27 | +42.05% | 24 | ||||||
| 267.77 | +24.82% | 18 | ||||||
| 581.83 | +0.82% | 12 | ||||||
| 72.53 | +6.41% | 14 | ||||||
| 184.62 | +12.88% | 16 | ||||||
| 69.73 | -3.28% | 11 | ||||||
| 138.56 | +30.35% | 6 | ||||||
| 130.53 | -2.66% | 12 | ||||||
| 133.31 | -2.44% | 13 | ||||||
| 37.73 | +2.53% | 11 | ||||||
| 89.14 | +72.19% | 21 | ||||||
| 127.18 | +23% | 22 | ||||||
| 610.05 | +98.18% | 19 | ||||||
| 44.07 | +6.45% | 14 | ||||||
| 56 | +14.31% | 17 | ||||||
| Average | 14,175.56 | +21.30% | 17 | ||||||
| Weighted average by Cap. | 23,339.87 | +20.94% | 19 |
Select your edition
All financial news and data tailored to specific country editions
